Asthma Therapeutics in Major Developed Markets to 2020- Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations Published on – 28 February, 2015 | Number of pages : 142 Single User Price: $4995 “The Asthma Therapeutics Market is forecast to grow marginally over the forecast period across the top eight developed nations, from $18.4 billion in 2013 to a projected value of $21.7 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 2.4%.”
Summary of the Report: MarketIntelReports Research, a leading business intelligence provider, has released its latest research report,"Asthma Therapeutics in Major Developed Markets to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations".The Asthma Therapeutics Market is forecast to grow marginally over the forecast period across the top eight developed nations, from $18.4 billion in 2013 to a projected value of $21.7 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 2.4%. This is in spite of generic erosion facing several of the leading asthma brands, such as Advair (fluticasone propionate/salmeterol xinafoate), Symbicort (budesonide/formoterol fumarate) and Xolair (omalizumab), and is a consequence of new market entrants and rising disease prevalence. The global prevalence of asthma is significant, believed to affect approximately 300 million people worldwide. This burden is predicted to increase in future, reaching 400 million by 2025. Although the majority of asthma patients are able to manage their symptoms effectively using currently marketed products, some remain inadequately controlled with these same products. This unmet need, coupled with rising global prevalence, has resulted in strong industry interest.
Click Here To Check Complete Report
Scope of the Report: The report covers and includes - An introduction to asthma, including discussion of disease epidemiology, etiology pathophysiology, symptoms, diagnosis, and treatment, with clinical data for drugs featured in the current treatment algorithm discussed in detail - In-depth analysis of the current marketed products landscape, including product profiles of the main drugs used and heat maps that compare their safety and efficacy parameters - Comprehensive analysis of the asthma pipeline by phase of development, molecule type, and molecular target and novelty, and comparative analysis of the most promising late-stage pipeline drugs, as well as heat maps and a competitor matrix that compares safety and efficacy parameters - Additional in-depth analysis of the asthma clinical trials landscape, including trends in size, duration and failure rate
Download Sample Brochure
Reasons to buy: The report will assist business development and enable marketing executives to strategize their product launches by allowing them to • Gain a comprehensive understanding of asthma, including diagnosis, disease severity, and treatment algorithms • Understand the current asthma marketed products landscape and recognize the dominant therapeutic agents and pharmaceutical players involved • Identify trends, developments, and prominent molecule types and molecular targets within the asthma pipeline • Gain an appreciation of the clinical and commercial aspects of the most promising latestage pipeline molecules and their potential competitive impact on the future market • Consider market opportunities and potential risks by examining trends in asthma clinical trial size, duration and failure rate, phase of development, molecule type, and molecular target • Observe projections for treatment usage patterns, annual therapy costs, and market growth in the eight major markets and understand reasons for variance in projected patterns of growth
Make an Inquiry Before Buying
Asthma Therapeutics in Major Developed Markets to 2020- Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations A detailed qualitative analysis of the factors responsible for driving and restraining growth of the Asthma Therapeutics Market are provided in the report.
Contact: 1-302-684-6088 sales@marketintelreports.com www.marketintelreports.com
Click here to order a copy of Asthma Therapeutics Market Report